Although clinical and demographic measures were the most informative predictors of outcomes, models using only changes in regional brain volumes as predictors were highly significant and explained between 1 and 10% of outcome variability across symptom dimensions and remain valuable.
← all excerpts
Accounting for symptom heterogeneity can improve neuroimaging models of antidepressant response after electroconvulsive therapy.
1
—
—